Stock Earnings

Question 1

Innate Pharma SAの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Innate Pharma SAの総資産は$111で、純lossは$-49です。

Question 2

IPHYFの主要な財務比率は何ですか？

Accepted Answer

Innate Pharma SAの流動比率は1.08、純利益率は-408.33、1株当たり売上高は$0.14です。

Question 3

Innate Pharma SAの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Innate Pharma SA largest revenue segment is Research and Development of Pharmaceutical Products, at a revenue of 20,121,000 in the most earnings release.For geography, France is the primary market for Innate Pharma SA, at a revenue of 20,121,000.

Question 4

Innate Pharma SAは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Innate Pharma SAの純lossは$-49です。

Question 5

Innate Pharma SAに負債はありますか？

Accepted Answer

yes、Innate Pharma SAの負債は102です。

Question 6

Innate Pharma SAの発行済株式数は何株ですか？

Accepted Answer

Innate Pharma SAの総発行済株式数は83.81株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	6	12	51	49	12	56
Revenue Growth (YoY)	-75%	-76%	4%	308%	-79%	-18%
Cost of Revenue	3	3	2	3	3	3
Gross Profit	2	9	49	45	9	52
Selling, General & Admin	18	18	16	20	23	17
Research & Development	37	45	49	45	41	37
Operating Expenses	53	61	61	62	56	51
Other Non Operating Income (Expenses)	0	1	1	-1	1	0
Pretax Income	-46	-49	-7	-57	-45	0
Income Tax Expense	0	0	0	0	0	0
Net Income	-46	-49	-7	-58	-52	-63
Net Income Growth	35%	600%	-88%	12%	-17%	215%
Shares Outstanding (Diluted)	86.93	81.05	80.45	79.63	79.54	78.93
Shares Change (YoY)	8%	1%	1%	0%	1%	18%
EPS (Diluted)	-0.54	-0.61	-0.09	-0.72	-0.66	-0.81
EPS Growth	30%	549%	-87%	10%	-19%	161%
Free Cash Flow	-41	-7	-34	-20	-59	-63
Free Cash Flow Per Share	-0.47	-0.08	-0.42	-0.25	-0.74	-0.79
Gross Margin	33.33%	75%	96.07%	91.83%	75%	92.85%
Operating Margin	-833.33%	-425%	-23.52%	-32.65%	-391.66%	1.78%
Profit Margin	-766.66%	-408.33%	-13.72%	-118.36%	-433.33%	-112.5%
Free Cash Flow Margin	-683.33%	-58.33%	-66.66%	-40.81%	-491.66%	-112.5%
EBITDA	-49	-50	-7	29	-43	57
EBITDA Margin	-816.66%	-416.66%	-13.72%	59.18%	-358.33%	101.78%
D&A For EBITDA	1	1	5	45	4	56
EBIT	-50	-51	-12	-16	-47	1
EBIT Margin	-833.33%	-425%	-23.52%	-32.65%	-391.66%	1.78%
Effective Tax Rate	0%	0%	0%	0%	0%	0%

Innate Pharma SA (IPHYF) Price

IPHYF Stock Price Chart

IPHYF Income

Follow-Up Questions